Revised Risk Estimation and Treatment Stratification of Low- and Intermediate-Risk Neuroblastoma Patients by Integrating Clinical and Molecular Prognostic Markers

André Oberthuer, Matthias Fischer, Andreas Faldum, Carolina Sterz(University of Cologne), Monika Ortmann(University of Cologne), Frank Westermann(German Cancer Research Center), Smadar Avigad(Schneider Children's Medical Center), Miki Ohira(Chiba Cancer Center), Olivier Delattre(Institut Curie), Isaac Yaniv(Tel Aviv University), Roland Eils(Heidelberg University), Frank Berthold(University Hospital Cologne), Gian Paolo Tonini(Città della Speranza Foundation), Dilafruz Juraeva(National Center for Tumor Diseases), Benedikt Brors(German Cancer Research Center), Isabelle Janoueix‐Lerosey(Inserm), Akira Nakagawara(Chiba Cancer Center), Rosa Noguera(Universitat de València), Ruth Volland(University Hospital Cologne), Richard G. Grundy(Brain Tumour Research), Robert C. Seeger(Children's Hospital of Los Angeles), Marta Piqueras(Universitat de València), Barbara Hero(University Hospital Cologne), Gudrun Schleiermacher(Inserm), Paola Scaruffi(Ospedale Policlinico San Martino), Thorsten Simon(University of Cologne), Yvonne Kahlert(University of Cologne), Jo Vandesompele(Ghent University Hospital), Shahab Asgharzadeh(Children's Hospital of Los Angeles), René Schmidt(University of Münster), Frank Speleman(Ghent University Hospital), Chunxuan Shao(German Cancer Research Center), Jean Bénard(Institut Gustave Roussy), Manfred Schwab(German Cancer Research Center), Anne Engesser(University Hospital Cologne), Alexander Valent(Institut Gustave Roussy), Jessica Theißen(University Hospital Cologne)
Clinical Cancer Research
September 18, 2014
Cited by 99


Related Papers